课题基金 / 基金详情

TREATMENT OF HAIRY CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE

TREATMENT OF HAIRY CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE
用 2-氯脱氧腺苷治疗毛细胞白血病
批准号：
6245002
负责人：
Eugene P Orringer
金额：
$1.34万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-01-06 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6245002
关键词：
chlorodeoxyadenosine clinical research clinical trials drug screening /evaluation drug tolerance hairy cell leukemia human mortality human subject human therapy evaluation neoplasm /cancer chemotherapy neoplasm /cancer pharmacology pharmacokinetics

项目摘要

项目成果

Eugene P Orringer的其他基金

相似基金

相关文献

中文摘要
翻译
该方案的目的是使2-CDA可用于治疗 对于不符合条件的活动期毛细胞性白血病患者 参与其他临床试验。该议定书将有助于 毒性、应答率、有效时间、持续时间的测定 毛细胞性白血病患者的反应和存活率 用2-CDA治疗。
英文摘要
The purpose of this protocol is to make 2-CdA available as a treatment for patients with active hairy cell leukemia who are not eligible to participate in other clinical trials. This protocol will contribute to the determination of toxicity, response rate, time to response, duration of response and survival of patients with hairy cell leukemia who are treated with 2-CdA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PERMEABILITY & METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS
CLINICAL TRIAL: NEUROPSYCHOLOGICAL DYSFUNCTION AND NEUROIMAGING ABNORMALITIES IN
NEUROPSYCHOLOGICAL DYSFUNCTION AND NEUROIMAGING ABNORMALITIES IN SCD
PERMEABILITY & METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS
海外基金